The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer's disease diagnostic revolution

被引：21
|
作者：
Schindler, Suzanne E. [1 ,2 ]
Atri, Alireza [3 ,4 ,5 ]
机构：
[1] Washington Univ St Louis, Dept Neurol, St Louis, MO 63130 USA
[2] Charles F & Joanne Knight Alzheimer Dis Res Ctr, St Louis, MO 63130 USA
[3] Banner Hlth, Banner Sun Hlth Res Inst, Sun City, AZ USA
[4] Brigham & Womens Hosp, Ctr Brain Mind Med, Dept Neurol, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
来源：
NATURE AGING | 2023年 / 3卷 / 05期
关键词：
TAU;
D O I：
10.1038/s43587-023-00400-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A major transformation in dementia diagnosis and care appears imminent and will depend on three major types of biomarkers: molecular imaging, blood-based biomarkers and cerebrospinal fluid biomarkers. Each modality has unique strengths and limitations that suggest its optimal uses in research, clinical trials and clinical diagnosis.
引用
收藏
页码：460 / 462
页数：3
相关论文
共 50 条
  • [1] The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer’s disease diagnostic revolution
    Suzanne E. Schindler
    Alireza Atri
    Nature Aging, 2023, 3 : 460 - 462
  • [2] A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles
    Lehmann, Sylvain
    Dumurgier, Julien
    Schraen, Susanna
    Wallon, David
    Blanc, Frederic
    Magnin, Eloi
    Bombois, Stephanie
    Bousiges, Olivier
    Campion, Dominique
    Cretin, Benjamin
    Delaby, Constance
    Hannequin, Didier
    Jung, Barbara
    Hugon, Jacques
    Laplanche, Jean-Louis
    Miguet-Alfonsi, Carole
    Peoc'h, Katell
    Philippi, Nathalie
    Quillard-Muraine, Muriel
    Sablonniere, Bernard
    Touchon, Jacques
    Vercruysse, Olivier
    Paquet, Claire
    Pasquier, Florence
    Gabelle, Audrey
    ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (03)
  • [3] A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
    Sylvain Lehmann
    Julien Dumurgier
    Susanna Schraen
    David Wallon
    Frédéric Blanc
    Eloi Magnin
    Stéphanie Bombois
    Olivier Bousiges
    Dominique Campion
    Benjamin Cretin
    Constance Delaby
    Didier Hannequin
    Barbara Jung
    Jacques Hugon
    Jean-Louis Laplanche
    Carole Miguet-Alfonsi
    Katell Peoc’h
    Nathalie Philippi
    Muriel Quillard-Muraine
    Bernard Sablonnière
    Jacques Touchon
    Olivier Vercruysse
    Claire Paquet
    Florence Pasquier
    Audrey Gabelle
    Alzheimer's Research & Therapy, 6
  • [4] Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease
    Niemantsverdriet, Ellis
    Goossens, Joery
    Struyfs, Hanne
    Martin, Jean-Jacques
    Goeman, Johan
    De Deyn, Peter Paul
    Vanderstichele, Hugo
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (01) : 97 - 106
  • [5] β-amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease
    Andreasen, N
    Blennow, K
    PEPTIDES, 2002, 23 (07) : 1205 - 1214
  • [6] Recent cerebrospinal fluid biomarker studies of Alzheimer's disease
    Choi, Yong Seok
    Choe, Leila H.
    Lee, Kelvin H.
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (06) : 919 - 926
  • [7] Cerebrospinal fluid α-synuclein as a potential biomarker for Alzheimer's disease
    Li, JieQiong
    Yu, Jintai
    Tan, Lan
    NEUROLOGY, 2018, 90
  • [8] Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
    Shahim, Pashtun
    Blennow, Kaj
    Johansson, Per
    Svensson, Johan
    Lista, Simone
    Hampel, Harald
    Andersson, Leif Christer
    Zetterberg, Henrik
    NEUROMOLECULAR MEDICINE, 2017, 19 (01) : 154 - 160
  • [9] Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer’s Disease and Other Neurodegenerative Disorders
    Pashtun Shahim
    Kaj Blennow
    Per Johansson
    Johan Svensson
    Simone Lista
    Harald Hampel
    Leif Christer Andersson
    Henrik Zetterberg
    NeuroMolecular Medicine, 2017, 19 : 154 - 160
  • [10] Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders
    Nilsson, Johanna
    Cousins, Katheryn A. Q.
    Gobom, Johan
    Portelius, Erik
    Chen-Plotkin, Alice
    Shaw, Leslie M.
    Grossman, Murray
    Irwin, David J.
    Trojanowski, John Q.
    Zetterberg, Henrik
    Blennow, Kaj
    Brinkmalm, Ann
    ALZHEIMERS & DEMENTIA, 2023, 19 (05) : 1775 - 1784
12345